This briefing on HPV and vaccination explains the disproportionate global burden of cervical cancer on Lower Middle Income Countries and the significant barriers in the implementation of vaccination programs.
Related content
Overview The global community of practice around HPV vaccination is not formalised to cut across multiple disciplines, and thought leaders from low-…
The slide deck explains the global burden of HPV-related cervical cancer, the current landscape of HPV vaccines,…
This 2-page briefing provides an overview of the key trends and insights observed across the three waves of data collection that have been conducted as part…
Overview Human Papillomavirus (HPV) is the fourth biggest cause of mortality amongst women in Brazil according to the Pan American Health Organisation (PAHO) but COVID-19…
The VCP-Africa CDC working group has been conducting quantitative research in multiple waves from 2020 to 2022.
Overview The Vaccine Confidence Project at the London School of Hygiene & Tropical Medicine, in partnership with Premise, developed ASSURE – Assessing Signals and Supporting Resilience.